Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13085858 | 0.99 | POLB (0.35) | POLBELANESIGMAR1KDM4EMEN1 | |
| SCHEMBL13085808 | 0.95 | POLB (0.32) | POLBELANESIGMAR1 | |
| SCHEMBL13085763 | 0.93 | POLB (0.38) | POLBELANEKDM4EMEN1MAPT | |
| SCHEMBL13085860 | 0.93 | POLB (0.38) | POLBELANEKDM4EMEN1MAPT | |
| SCHEMBL13085833 | 0.93 | POLB (0.33) | POLBELANE | |
| SCHEMBL13085749 | 0.93 | POLB (0.34) | POLBELANE | |
| SCHEMBL24647456 | 0.92 | SIGMAR1 (0.32) | SIGMAR1KDM4EMEN1MAPTMAPK1 | |
| SCHEMBL13085711 | 0.90 | SIGMAR1 (0.31) | POLBSIGMAR1MEN1KMT2A | |
| SCHEMBL13085856 | 0.89 | POLB (0.35) | POLBELANEKDM4EMEN1MAPT | |
| SCHEMBL31651410 | 0.88 | SIGMAR1 (0.38) | SIGMAR1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7811682-B2 | Compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2010-10-12 | — | — | US | disclosed |
| US-7811682-B2 | Compound and organic light emitting device using the same | LG CHEM, LTD. (KR) | 2010-10-12 | — | — | US | disclosed |
| US-20080303434-A1 | Compound and Organic Light Emitting Device Using the Same | LG CHEM, LTD. (KR) | 2008-12-11 | — | — | US | disclosed |
| US-20080303434-A1 | Compound and Organic Light Emitting Device Using the Same | LG CHEM, LTD. (KR) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080303434-A1 | Compound and Organic Light Emitting Device Using the Same | PPOX, CRY1, CRY2 | POLB 890/4885ELANE 2080/4885SIGMAR1 4092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.